xPoint Diagnostics Ltd.
x Point Diagnostics Ltd. is a start-up company founded in 2020, dedicated to the research and development of Point-of-Care in-vitro diagnostic assay devices, particularly focusing on obstetrics and trauma. Their flagship product, the F-Point, is a compact and rapid fibrinogen assay designed for use in operating theatres and emergency rooms, enabling critical clinical decision-making within a 7-minute turnaround time. The technology utilizes a patented method combining differential laser nephelometry and machine learning for accurate fibrinogen concentration determination from whole blood samples. With a strong emphasis on innovation, x Point aims to address significant unmet medical needs in bleeding management, positioning itself as a leader in the Point-of-Care diagnostics market.
xPoint Diagnostics Ltd.
x Point Diagnostics Ltd. is a start-up company founded in 2020, dedicated to the research and development of Point-of-Care in-vitro diagnostic assay devices, particularly focusing on obstetrics and trauma. Their flagship product, the F-Point, is a compact and rapid fibrinogen assay designed for use in operating theatres and emergency rooms, enabling critical clinical decision-making within a 7-minute turnaround time. The technology utilizes a patented method combining differential laser nephelometry and machine learning for accurate fibrinogen concentration determination from whole blood samples. With a strong emphasis on innovation, x Point aims to address significant unmet medical needs in bleeding management, positioning itself as a leader in the Point-of-Care diagnostics market.